Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Regen BioPharma (RGBPP) over the last 8 years, with Q4 2025 value amounting to $27425.0.

  • Regen BioPharma's Change in Receivables changed 0.36% to $27425.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $110001.0, marking a year-over-year change of 0.09%. This contributed to the annual value of $110000.0 for FY2025, which is 1594.33% up from last year.
  • Per Regen BioPharma's latest filing, its Change in Receivables stood at $27425.0 for Q4 2025, which was up 0.36% from $27726.0 recorded in Q3 2025.
  • Regen BioPharma's Change in Receivables' 5-year high stood at $27726.0 during Q3 2021, with a 5-year trough of -$122575.0 in Q4 2022.
  • Moreover, its 5-year median value for Change in Receivables was $27424.5 (2021), whereas its average is $5084.2.
  • In the last 5 years, Regen BioPharma's Change in Receivables plummeted by 54694.62% in 2022 and then skyrocketed by 22148.39% in 2024.
  • Quarter analysis of 5 years shows Regen BioPharma's Change in Receivables stood at $27425.0 in 2021, then tumbled by 546.95% to -$122575.0 in 2022, then surged by 110.03% to $12298.0 in 2023, then soared by 123.0% to $27424.0 in 2024, then rose by 0.0% to $27425.0 in 2025.
  • Its Change in Receivables stands at $27425.0 for Q4 2025, versus $27726.0 for Q3 2025 and $27427.0 for Q2 2025.